Viewing Study NCT05554432


Ignite Creation Date: 2025-12-24 @ 9:25 PM
Ignite Modification Date: 2026-02-01 @ 12:19 PM
Study NCT ID: NCT05554432
Status: UNKNOWN
Last Update Posted: 2022-11-03
First Post: 2022-09-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Development of an EORTC Immune Checkpoint Inhibitor-specific Quality of Life Item List: Phase 1 & 2
Sponsor: Institut Curie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
None IMMUNE CHECKPOINT INHIBITOR View
None Quality of Life View
Keywords: